Greg Meiselbach

Greg Meiselbach is a seasoned professional in international government relations and advocacy, currently serving as Principal at The Shelburne Group since August 2016. In addition to this role, Greg holds positions as a Board Member for the Montana Bioscience Alliance and as an Advisor for IACTA Pharmaceuticals, while previously acting as Senior Advisor for Tonix Pharmaceuticals until February 2023. With extensive experience at the Biotechnology Innovation Organization, Greg managed international advocacy efforts across the Asia Pacific region, focusing on trade and regulatory issues. Earlier roles include Manager at Frontier Strategy Group, where strategic advisory services were provided to Fortune 500 executives, and Legislative Assistant at UPS Corporate Public Affairs, handling legislative and regulatory issues related to international trade. Education includes attendance at Tufts University, the International School of Beijing, and The American School in Japan.